
Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
Author(s) -
Justin P. Zachariah,
Twalib Aliku,
Amy Scheel,
Babar Hasan,
Peter Lwabi,
Craig Sable,
Andrea Beaton
Publication year - 2016
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/0974-2069.180668
Subject(s) - medicine , heart disease , heart failure , natriuretic peptide , brain natriuretic peptide , ejection fraction , cardiology , guideline , pathology
Rheumatic heart disease (RHD) is a global cause of early heart failure. Early RHD is characterized by valvar regurgitation, leading to ventricular distention and possible elaboration of amino-terminal pro-brain natriuretic peptide (NT-proBNP). We investigated the ability of NT-proBNP to distinguish cases of latent RHD detected by echocardiographic screening from the controls.